Hutchmed, Innovent receive NMPA nod for fruquintinib in combo with sintilimab injection to treat patients with metastatic renal cell carcinoma: Hong Kong, Shanghai Saturday, May 2 ...
Key Points Interested in Exelixis, Inc.? Here are five stocks we like better. Exelixis is leaning on CABO growth in renal ...
Renal cell carcinoma (RCC) is one of the 10 most commonly diagnosed solid tumors. Most RCCs are histologically defined as clear cell, comprising approximately 75% of diagnoses. However, the remaining ...
The management of renal cell carcinoma (RCC) has transformed over the past 20 years, and recent advances in diagnostic and therapeutic modalities have the potential to further improve patient outcomes ...
A new analysis of U.S. military personnel included Black, White, and Hispanic adults newly diagnosed with primary stage I-III RCC between 1998 and 2014. Hispanic and White patients had similar rates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results